Dr. Adnan Qureshi, M.D

NPI: 1154641702
Total Payments
$5,966
2024 Payments
$4,864
Companies
11
Transactions
21
Medicare Patients
1,551
Medicare Billing
$518,278

Payment Breakdown by Category

Consulting$4,980 (83.5%)
Travel$531.69 (8.9%)
Food & Beverage$454.16 (7.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $4,980 2 83.5%
Travel and Lodging $531.69 3 8.9%
Food and Beverage $454.16 16 7.6%

Top Paying Companies

Company Total Records Latest Year
Chiesi USA, Inc. $4,830 1 $0 (2024)
Stryker Corporation $591.69 5 $0 (2017)
Relievant Medsystems, Inc. $162.24 1 $0 (2022)
Alkermes, Inc. $150.00 1 $0 (2017)
Horizon Therapeutics plc $93.20 6 $0 (2021)
Merck Sharp & Dohme LLC $33.92 1 $0 (2024)
Vertical Pharmaceuticals, LLC $32.27 2 $0 (2019)
GlaxoSmithKline, LLC. $23.51 1 $0 (2023)
Eisai Inc. $17.83 1 $0 (2017)
Teva Pharmaceuticals USA, Inc. $15.98 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $4,864 2 Chiesi USA, Inc. ($4,830)
2023 $23.51 1 GlaxoSmithKline, LLC. ($23.51)
2022 $178.22 2 Relievant Medsystems, Inc. ($162.24)
2021 $14.76 1 Horizon Therapeutics plc ($14.76)
2020 $54.10 3 Horizon Therapeutics plc ($54.10)
2019 $39.54 3 Horizon Therapeutics plc ($24.34)
2017 $791.80 9 Stryker Corporation ($591.69)

All Payment Transactions

21 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/16/2024 Chiesi USA, Inc. Consulting Fee Cash or cash equivalent $4,830.00 General
08/01/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $33.92 General
Category: ONCOLOGY
09/15/2023 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $23.51 General
Category: VACCINES
10/21/2022 Relievant Medsystems, Inc. Intracept (Device), Intracept Food and Beverage Cash or cash equivalent $162.24 General
Category: Pain
07/01/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $15.98 General
Category: Central Nervous System
02/05/2021 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $14.76 General
Category: PENNSAID
05/26/2020 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $16.56 General
Category: PENNSAID
05/20/2020 Horizon Therapeutics plc RAYOS (Drug), RAYOS, RAYOS Food and Beverage In-kind items and services $22.86 General
Category: RAYOS
02/19/2020 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $14.68 General
Category: PENNSAID
10/03/2019 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $12.89 General
Category: PENNSAID
08/06/2019 Vertical Pharmaceuticals, LLC LORZONE (Drug) Food and Beverage In-kind items and services $15.20 General
Category: MUSCLE RELAXANT
05/21/2019 Horizon Therapeutics plc PENNSAID (Drug) Food and Beverage In-kind items and services $11.45 General
Category: PENNSAID
06/27/2017 Alkermes, Inc. Consulting Fee Cash or cash equivalent $150.00 General
02/25/2017 Stryker Corporation IVS - Vertebral Augmentation Products (Device) Travel and Lodging Cash or cash equivalent $160.21 General
Category: Interventional Spine
02/25/2017 Stryker Corporation IVS - Vertebral Augmentation Products (Device) Travel and Lodging Cash or cash equivalent $34.94 General
Category: Interventional Spine
02/25/2017 Stryker Corporation IVS - RF Cannulae/Needles (Device) Food and Beverage Cash or cash equivalent $30.00 General
Category: Interventional Spine
02/25/2017 Stryker Corporation IVS - RF Cannulae/Needles (Device) Food and Beverage Cash or cash equivalent $30.00 General
Category: Interventional Spine
02/22/2017 Eisai Inc. Fycompa (Drug) Food and Beverage Cash or cash equivalent $17.83 General
Category: Neurology
02/08/2017 Stryker Corporation IVS - Vertebral Augmentation Products (Device) Travel and Lodging Cash or cash equivalent $336.54 General
Category: Interventional Spine
01/18/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $15.21 General
Category: Opioid Induced Constipation
01/11/2017 Vertical Pharmaceuticals, LLC LORZONE (Drug), CONZIP Food and Beverage In-kind items and services $17.07 General
Category: MUSCLE RELAXANT

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 365 7,082 $503,344 $155,641
2022 9 338 4,894 $352,388 $115,063
2021 12 425 6,371 $444,343 $149,074
2020 11 423 4,404 $303,856 $98,499
Total Patients
1,551
Total Services
22,751
Medicare Billing
$518,278
Procedure Codes
41

All Medicare Procedures & Services

41 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
97110 Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes Office 2023 88 3,760 $282,902 $75,025 26.5%
97124 Therapy procedure using massage, each 15 minutes Office 2023 70 1,128 $70,523 $30,861 43.8%
97112 Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes Office 2023 14 508 $41,321 $14,296 34.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 62 133 $23,940 $10,475 43.8%
97116 Therapy procedure for walking training, each 15 minutes Office 2023 15 399 $26,150 $7,972 30.5%
97032 Application of electrical stimulation with therapist present, each 15 minutes Office 2023 47 559 $24,998 $5,671 22.7%
97140 Therapy procedure using manual technique, each 15 minutes Office 2023 19 269 $18,475 $5,043 27.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 38 38 $9,850 $3,905 39.6%
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care Office 2023 12 288 $5,184 $2,393 46.2%
97110 Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes Office 2022 84 2,578 $193,969 $53,744 27.7%
97124 Therapy procedure using massage, each 15 minutes Office 2022 69 962 $60,144 $26,649 44.3%
97112 Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes Office 2022 11 370 $30,096 $10,423 34.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 63 123 $22,140 $9,776 44.2%
97032 Application of electrical stimulation with therapist present, each 15 minutes Office 2022 47 566 $25,312 $5,911 23.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 21 21 $8,203 $3,048 37.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 15 20 $5,058 $2,289 45.3%
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care Office 2022 16 242 $4,356 $2,104 48.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 12 12 $3,111 $1,120 36.0%
97110 Therapeutic exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes Office 2021 90 2,970 $223,463 $62,662 28.0%
97124 Therapeutic massage to 1 or more areas, each 15 minutes Office 2021 78 1,350 $84,402 $35,624 42.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 73 190 $33,405 $15,462 46.3%
97112 Therapeutic procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes Office 2021 15 426 $34,651 $12,493 36.1%
97032 Application of electrical stimulation to 1 or more areas, each 15 minutes Office 2021 52 649 $29,023 $6,918 23.8%
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care Office 2021 24 546 $9,828 $5,015 51.0%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 33 33 $8,554 $3,469 40.6%

About Dr. Adnan Qureshi, M.D

Dr. Adnan Qureshi, M.D is a Physical Medicine & Rehabilitation healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2010. The National Provider Identifier (NPI) number assigned to this provider is 1154641702.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adnan Qureshi, M.D has received a total of $5,966 in payments from pharmaceutical and medical device companies, with $4,864 received in 2024. These payments were reported across 21 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($4,980).

As a Medicare-enrolled provider, Qureshi has provided services to 1,551 Medicare beneficiaries, totaling 22,751 services with total Medicare billing of $518,278. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.

Practice Information

  • Specialty Physical Medicine & Rehabilitation
  • Other Specialties Pain Medicine
  • Location Bronx, NY
  • Active Since 06/06/2010
  • Last Updated 03/17/2018
  • Taxonomy Code 208100000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1154641702

Products in Payments

  • IVS - Vertebral Augmentation Products (Device) $531.69
  • Intracept (Device) $162.24
  • PENNSAID (Drug) $70.34
  • IVS - RF Cannulae/Needles (Device) $60.00
  • KEYTRUDA (Biological) $33.92
  • LORZONE (Drug) $32.27
  • SHINGRIX (Biological) $23.51
  • RAYOS (Drug) $22.86
  • Fycompa (Drug) $17.83
  • AUSTEDO (Drug) $15.98
  • Movantik (Drug) $15.21

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physical Medicine & Rehabilitation Doctors in Bronx